Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-05

Clinical Trial Update: Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3 [Phase 1]

View source ↗

Summary

Phase 1 study examining determinants of alpha-aminoadipic acid (2-AAA) and its relationship to Type 2 diabetes; study completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2024-06-05